Future investigations incorporating multi-compartmental sampling (e.g., cutaneous and circulating tissues) are warranted to elucidate the tissue-specific regulatory mechanisms governing NEK6 expression in SSc pathogenesis. Here, NEK6 is linked to systemic sclerosis.